FDA approves first gene therapy for sickle cell disease

FDA approves first gene therapy for sickle cell disease – CBS News


Watch CBS News



The Food and Drug Administration on Friday approved the first-ever gene-editing therapy that uses a cutting-edge technology called CRISPR to treat sickle cell disease. Dr. Jon LaPook has more.

View CBS News In

Be the first to know

Get browser notifications for breaking news, live events, and exclusive reporting.


This post was originally published on CBS News

Share your love